| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |